4-[(4-tert-butyl-2-chlorophenyl)methyl]morpholine;2-[(3-tert-butyl-5-fluorophenoxy)methyl]-1-methylpyrrolidine;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-(2-fluoroethyl)piperazine;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-methyl-1,4-diazepane;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-3-methylpiperazine;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-methylpiperazine;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-propan-2-ylpiperazine

C120H178ClF17N12O2 — CID 158764934

IUPAC4-[(4-tert-butyl-2-chlorophenyl)methyl]morpholine;2-[(3-tert-butyl-5-fluorophenoxy)methyl]-1-methylpyrrolidine;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-(2-fluoroethyl)piperazine;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-methyl-1,4-diazepane;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-3-methylpiperazine;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-methylpiperazine;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-propan-2-ylpiperazine
SMILESCC(C)(C)c1ccc(CN2CCN(CCF)CC2)c(C(F)(F)F)c1.CC(C)(C)c1ccc(CN2CCOCC2)c(Cl)c1.CC(C)N1CCN(Cc2ccc(C(C)(C)C)cc2C(F)(F)F)CC1.CC1CN(Cc2ccc(C(C)(C)C)cc2C(F)(F)F)CCN1.CN1CCCC1COc1cc(F)cc(C(C)(C)C)c1.CN1CCCN(Cc2ccc(C(C)(C)C)cc2C(F)(F)F)CC1.CN1CCN(Cc2ccc(C(C)(C)C)cc2C(F)(F)F)CC1
InChIInChI=1S/C19H29F3N2.C18H26F4N2.C18H27F3N2.2C17H25F3N2.C16H24FNO.C15H22ClNO/c1-14(2)24-10-8-23(9-11-24)13-15-6-7-16(18(3,4)5)12-17(15)19(20,21)22;1-17(2,3)15-5-4-14(16(12-15)18(20,21)22)13-24-10-8-23(7-6-19)9-11-24;1-17(2,3)15-7-6-14(16(12-15)18(19,20)21)13-23-9-5-8-22(4)10-11-23;1-16(2,3)14-6-5-13(15(11-14)17(18,19)20)12-22-9-7-21(4)8-10-22;1-12-10-22(8-7-21-12)11-13-5-6-14(16(2,3)4)9-15(13)17(18,19)20;1-16(2,3)12-8-13(17)10-15(9-12)19-11-14-6-5-7-18(14)4;1-15(2,3)13-5-4-12(14(16)10-13)11-17-6-8-18-9-7-17/h6-7,12,14H,8-11,13H2,1-5H3;4-5,12H,6-11,13H2,1-3H3;6-7,12H,5,8-11,13H2,1-4H3;5-6,11H,7-10,12H2,1-4H3;5-6,9,12,21H,7-8,10-11H2,1-4H3;8-10,14H,5-7,11H2,1-4H3;4-5,10H,6-9,11H2,1-3H3
InChIKeyIPDDWYXRTYQQCD-UHFFFAOYSA-N
MW2179.24 g/mol
LogP27.37
Rot. Bonds18

About 4-[(4-tert-butyl-2-chlorophenyl)methyl]morpholine;2-[(3-tert-butyl-5-fluorophenoxy)methyl]-1-methylpyrrolidine;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-(2-fluoroethyl)piperazine;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-methyl-1,4-diazepane;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-3-methylpiperazine;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-methylpiperazine;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-propan-2-ylpiperazine

4-[(4-tert-butyl-2-chlorophenyl)methyl]morpholine;2-[(3-tert-butyl-5-fluorophenoxy)methyl]-1-methylpyrrolidine;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-(2-fluoroethyl)piperazine;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-methyl-1,4-diazepane;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-3-methylpiperazine;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-methylpiperazine;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-propan-2-ylpiperazine (PubChem CID 158764934) has the molecular formula C120H178ClF17N12O2 and a molecular weight of 2179.24 g/mol. Its IUPAC name is 4-[(4-tert-butyl-2-chlorophenyl)methyl]morpholine;2-[(3-tert-butyl-5-fluorophenoxy)methyl]-1-methylpyrrolidine;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-(2-fluoroethyl)piperazine;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-methyl-1,4-diazepane;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-3-methylpiperazine;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-methylpiperazine;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-propan-2-ylpiperazine.

Molecular Properties

Compound Name4-[(4-tert-butyl-2-chlorophenyl)methyl]morpholine;2-[(3-tert-butyl-5-fluorophenoxy)methyl]-1-methylpyrrolidine;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-(2-fluoroethyl)piperazine;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-methyl-1,4-diazepane;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-3-methylpiperazine;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-methylpiperazine;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-propan-2-ylpiperazine
PubChem CID158764934
Molecular FormulaC120H178ClF17N12O2
Molecular Weight2179.24 g/mol
Exact Mass2177.36
IUPAC Name4-[(4-tert-butyl-2-chlorophenyl)methyl]morpholine;2-[(3-tert-butyl-5-fluorophenoxy)methyl]-1-methylpyrrolidine;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-(2-fluoroethyl)piperazine;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-methyl-1,4-diazepane;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-3-methylpiperazine;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-methylpiperazine;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-propan-2-ylpiperazine
SMILESCC(C)(C)c1ccc(CN2CCN(CCF)CC2)c(C(F)(F)F)c1.CC(C)(C)c1ccc(CN2CCOCC2)c(Cl)c1.CC(C)N1CCN(Cc2ccc(C(C)(C)C)cc2C(F)(F)F)CC1.CC1CN(Cc2ccc(C(C)(C)C)cc2C(F)(F)F)CCN1.CN1CCCC1COc1cc(F)cc(C(C)(C)C)c1.CN1CCCN(Cc2ccc(C(C)(C)C)cc2C(F)(F)F)CC1.CN1CCN(Cc2ccc(C(C)(C)C)cc2C(F)(F)F)CC1
InChIInChI=1S/C19H29F3N2.C18H26F4N2.C18H27F3N2.2C17H25F3N2.C16H24FNO.C15H22ClNO/c1-14(2)24-10-8-23(9-11-24)13-15-6-7-16(18(3,4)5)12-17(15)19(20,21)22;1-17(2,3)15-5-4-14(16(12-15)18(20,21)22)13-24-10-8-23(7-6-19)9-11-24;1-17(2,3)15-7-6-14(16(12-15)18(19,20)21)13-23-9-5-8-22(4)10-11-23;1-16(2,3)14-6-5-13(15(11-14)17(18,19)20)12-22-9-7-21(4)8-10-22;1-12-10-22(8-7-21-12)11-13-5-6-14(16(2,3)4)9-15(13)17(18,19)20;1-16(2,3)12-8-13(17)10-15(9-12)19-11-14-6-5-7-18(14)4;1-15(2,3)13-5-4-12(14(16)10-13)11-17-6-8-18-9-7-17/h6-7,12,14H,8-11,13H2,1-5H3;4-5,12H,6-11,13H2,1-3H3;6-7,12H,5,8-11,13H2,1-4H3;5-6,11H,7-10,12H2,1-4H3;5-6,9,12,21H,7-8,10-11H2,1-4H3;8-10,14H,5-7,11H2,1-4H3;4-5,10H,6-9,11H2,1-3H3
InChIKeyIPDDWYXRTYQQCD-UHFFFAOYSA-N
XLogP27.37
TPSA66.13 Ų
H-Bond Donors1
H-Bond Acceptors14
Rotatable Bonds18
Heavy Atoms152
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002179.24
LogP ≤ 527.37
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 1014

Analyze 4-[(4-tert-butyl-2-chlorophenyl)methyl]morpholine;2-[(3-tert-butyl-5-fluorophenoxy)methyl]-1-methylpyrrolidine;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-(2-fluoroethyl)piperazine;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-methyl-1,4-diazepane;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-3-methylpiperazine;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-methylpiperazine;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-propan-2-ylpiperazine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

4-[(4-tert-butyl-2-chlorophenyl)methyl]morpholine;2-[(3-tert-butyl-5-fluorophenoxy)methyl]-1-methylpyrrolidine;N-(2-tert-butyl-6-fluorophenyl)-N,1-dimethylpyrrolidin-3-amine;3-tert-butyl-N-(2-morpholin-4-ylethyl)-5-(trifluoromethyl)aniline;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-(2-fluoroethyl)piperazine;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-methyl-1,4-diazepane;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-3-methylpiperazine;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-methylpiperazine;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-propan-2-ylpiperazine
CID 158167226
1-[(4-tert-butyl-2-chlorophenyl)methyl]piperidine;2-[(3-tert-butyl-5-fluorophenoxy)methyl]-1-methylpyrrolidine;N-(2-tert-butyl-6-fluorophenyl)-N,1-dimethylpyrrolidin-3-amine;3-tert-butyl-N-(2-piperidin-1-ylethyl)-5-(trifluoromethyl)aniline;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-(2-fluoroethyl)piperazine;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-methyl-1,4-diazepane;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-methylpiperazine;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-3-methylpiperidine;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-propan-2-ylpiperazine
CID 161193539
4-[(4-tert-butyl-2-chlorophenyl)methyl]morpholine;1-[(3-tert-butyl-5-cyclopropylphenyl)methyl]-4-methylpiperazine;2-[(3-tert-butyl-5-fluorophenoxy)methyl]-1-methylpyrrolidine;N-(2-tert-butyl-6-fluorophenyl)-N,1-dimethylpyrrolidin-3-amine;3-tert-butyl-N-(2-morpholin-4-ylethyl)-5-(trifluoromethyl)aniline;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-(2-fluoroethyl)piperazine;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-methyl-1,4-diazepane;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-3-methylpiperazine;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-methylpiperazine;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-propan-2-ylpiperazine;(3R)-1-[[3-tert-butyl-5-(trifluoromethyl)phenyl]methyl]pyrrolidin-3-ol
CID 161830943
8-tert-butyl-5-chloro-1,2,3,4-tetrahydroisoquinoline;(4R)-8-tert-butyl-4-(difluoromethyl)-1,2,3,4-tetrahydroisoquinoline;(4S)-8-tert-butyl-4-(difluoromethyl)-1,2,3,4-tetrahydroisoquinoline;8-tert-butyl-5-fluoro-1,2,3,4-tetrahydroisoquinoline;(2S)-6-tert-butyl-2-methyl-2,3,4,5-tetrahydro-1,4-benzoxazepine;(2R)-6-tert-butyl-2-methyl-2,3,4,5-tetrahydro-1,4-benzoxazepine;(1S)-8-tert-butyl-1-methyl-1,2,3,4-tetrahydroisoquinoline;(1R)-8-tert-butyl-1-methyl-1,2,3,4-tetrahydroisoquinoline;8-tert-butyl-5-methyl-1,2,3,4-tetrahydroisoquinoline;tetrakis(8-tert-butyl-6-methyl-1,2,3,4-tetrahydroisoquinoline);(4S)-8-tert-butyl-4-(trifluoromethyl)-1,2,3,4-tetrahydroisoquinoline;methane
CID 162216345

Frequently Asked Questions

What is the IUPAC name of 4-[(4-tert-butyl-2-chlorophenyl)methyl]morpholine;2-[(3-tert-butyl-5-fluorophenoxy)methyl]-1-methylpyrrolidine;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-(2-fluoroethyl)piperazine;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-methyl-1,4-diazepane;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-3-methylpiperazine;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-methylpiperazine;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-propan-2-ylpiperazine?
The IUPAC name of 4-[(4-tert-butyl-2-chlorophenyl)methyl]morpholine;2-[(3-tert-butyl-5-fluorophenoxy)methyl]-1-methylpyrrolidine;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-(2-fluoroethyl)piperazine;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-methyl-1,4-diazepane;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-3-methylpiperazine;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-methylpiperazine;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-propan-2-ylpiperazine (CID 158764934) is 4-[(4-tert-butyl-2-chlorophenyl)methyl]morpholine;2-[(3-tert-butyl-5-fluorophenoxy)methyl]-1-methylpyrrolidine;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-(2-fluoroethyl)piperazine;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-methyl-1,4-diazepane;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-3-methylpiperazine;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-methylpiperazine;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-propan-2-ylpiperazine.
What is the SMILES notation for 4-[(4-tert-butyl-2-chlorophenyl)methyl]morpholine;2-[(3-tert-butyl-5-fluorophenoxy)methyl]-1-methylpyrrolidine;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-(2-fluoroethyl)piperazine;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-methyl-1,4-diazepane;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-3-methylpiperazine;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-methylpiperazine;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-propan-2-ylpiperazine?
The canonical SMILES for 4-[(4-tert-butyl-2-chlorophenyl)methyl]morpholine;2-[(3-tert-butyl-5-fluorophenoxy)methyl]-1-methylpyrrolidine;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-(2-fluoroethyl)piperazine;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-methyl-1,4-diazepane;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-3-methylpiperazine;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-methylpiperazine;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-propan-2-ylpiperazine is CC(C)(C)c1ccc(CN2CCN(CCF)CC2)c(C(F)(F)F)c1.CC(C)(C)c1ccc(CN2CCOCC2)c(Cl)c1.CC(C)N1CCN(Cc2ccc(C(C)(C)C)cc2C(F)(F)F)CC1.CC1CN(Cc2ccc(C(C)(C)C)cc2C(F)(F)F)CCN1.CN1CCCC1COc1cc(F)cc(C(C)(C)C)c1.CN1CCCN(Cc2ccc(C(C)(C)C)cc2C(F)(F)F)CC1.CN1CCN(Cc2ccc(C(C)(C)C)cc2C(F)(F)F)CC1.
What is the InChIKey of 4-[(4-tert-butyl-2-chlorophenyl)methyl]morpholine;2-[(3-tert-butyl-5-fluorophenoxy)methyl]-1-methylpyrrolidine;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-(2-fluoroethyl)piperazine;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-methyl-1,4-diazepane;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-3-methylpiperazine;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-methylpiperazine;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-propan-2-ylpiperazine?
The InChIKey is IPDDWYXRTYQQCD-UHFFFAOYSA-N. The full InChI is InChI=1S/C19H29F3N2.C18H26F4N2.C18H27F3N2.2C17H25F3N2.C16H24FNO.C15H22ClNO/c1-14(2)24-10-8-23(9-11-24)13-15-6-7-16(18(3,4)5)12-17(15)19(20,21)22;1-17(2,3)15-5-4-14(16(12-15)18(20,21)22)13-24-10-8-23(7-6-19)9-11-24;1-17(2,3)15-7-6-14(16(12-15)18(19,20)21)13-23-9-5-8-22(4)10-11-23;1-16(2,3)14-6-5-13(15(11-14)17(18,19)20)12-22-9-7-21(4)8-10-22;1-12-10-22(8-7-21-12)11-13-5-6-14(16(2,3)4)9-15(13)17(18,19)20;1-16(2,3)12-8-13(17)10-15(9-12)19-11-14-6-5-7-18(14)4;1-15(2,3)13-5-4-12(14(16)10-13)11-17-6-8-18-9-7-17/h6-7,12,14H,8-11,13H2,1-5H3;4-5,12H,6-11,13H2,1-3H3;6-7,12H,5,8-11,13H2,1-4H3;5-6,11H,7-10,12H2,1-4H3;5-6,9,12,21H,7-8,10-11H2,1-4H3;8-10,14H,5-7,11H2,1-4H3;4-5,10H,6-9,11H2,1-3H3.
What are the key properties of 4-[(4-tert-butyl-2-chlorophenyl)methyl]morpholine;2-[(3-tert-butyl-5-fluorophenoxy)methyl]-1-methylpyrrolidine;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-(2-fluoroethyl)piperazine;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-methyl-1,4-diazepane;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-3-methylpiperazine;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-methylpiperazine;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-propan-2-ylpiperazine?
4-[(4-tert-butyl-2-chlorophenyl)methyl]morpholine;2-[(3-tert-butyl-5-fluorophenoxy)methyl]-1-methylpyrrolidine;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-(2-fluoroethyl)piperazine;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-methyl-1,4-diazepane;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-3-methylpiperazine;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-methylpiperazine;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-propan-2-ylpiperazine has a molecular weight of 2179.24 g/mol, XLogP of 27.37, 18 rotatable bonds, 1 hydrogen bond donors, and 14 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[(4-tert-butyl-2-chlorophenyl)methyl]morpholine;2-[(3-tert-butyl-5-fluorophenoxy)methyl]-1-methylpyrrolidine;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-(2-fluoroethyl)piperazine;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-methyl-1,4-diazepane;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-3-methylpiperazine;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-methylpiperazine;1-[[4-tert-butyl-2-(trifluoromethyl)phenyl]methyl]-4-propan-2-ylpiperazine is sourced from PubChem (CID 158764934), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).